BlackRock
ABEO icon

BlackRock’s Abeona Therapeutics ABEO Stock Holding History

BlackRock’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3M Buy
3,195,530
+35,667
+1% +$178K ﹤0.01% 3272
2025
Q4 		$16.7M Buy
3,159,863
+12,713
+0.4% +$64K ﹤0.01% 3181
2025
Q3 		$16.6M Buy
3,147,150
+147,996
+5% +$939K ﹤0.01% 3198
2025
Q2 		$17M Buy
2,999,154
+2,481,675
+480% +$14.1M ﹤0.01% 3131
2025
Q1 		$2.46M Buy
517,479
+6,197
+1% +$33.7K ﹤0.01% 3927
2024
Q4 		$2.85M Buy
511,282
+31,720
+7% +$195K ﹤0.01% 3927
2024
Q3 		$3.03M Buy
479,562
+33,123
+7% +$173K ﹤0.01% 3871
2024
Q2 		$1.89M Buy
446,439
+225,890
+102% +$1.15M ﹤0.01% 3981
2024
Q1 		$1.6M Buy
220,549
+34,175
+18% +$217K ﹤0.01% 4074
2023
Q4 		$934K Buy
186,374
+45,425
+32% +$200K ﹤0.01% 4280
2023
Q3 		$593K Sell
140,949
-1,836
-1% -$6.95K ﹤0.01% 4376
2023
Q2 		$575K Buy
142,785
+87,057
+156% +$305K ﹤0.01% 4448
2023
Q1 		$157K Hold
55,728
– – ﹤0.01% 4842
2022
Q4 		$172K Hold
55,728
– – ﹤0.01% 4893
2022
Q3 		$169K Sell
55,728
-36
-0.1% -$148 ﹤0.01% 5020
2022
Q2 		$291K Sell
55,764
-12,021
-18% -$60.8K ﹤0.01% 4937
2022
Q1 		$534K Buy
67,785
+3,068
+5% +$21.1K ﹤0.01% 4847
2021
Q4 		$545K Sell
64,717
-495
-0.8% -$9.09K ﹤0.01% 4845
2021
Q3 		$1.83M Sell
65,212
-763
-1% -$24.4K ﹤0.01% 4358
2021
Q2 		$2.57M Sell
65,975
-133,262
-67% -$5.44M ﹤0.01% 4152
2021
Q1 		$9.36M Buy
199,237
+35,604
+22% +$1.96M ﹤0.01% 3610
2020
Q4 		$6.42M Buy
163,633
+7,758
+5% +$264K ﹤0.01% 3591
2020
Q3 		$3.98M Sell
155,875
-144
-0.1% -$9.08K ﹤0.01% 3666
2020
Q2 		$11.4M Buy
156,019
+9,404
+6% +$650K ﹤0.01% 3105
2020
Q1 		$7.7M Buy
146,615
+47,125
+47% +$3.15M ﹤0.01% 3129
2019
Q4 		$8.13M Sell
99,490
-1,504
-1% -$106K ﹤0.01% 3344
2019
Q3 		$5.71M Buy
100,994
+2,597
+3% +$194K ﹤0.01% 3447
2019
Q2 		$11.8M Buy
98,397
+5,502
+6% +$922K ﹤0.01% 3163
2019
Q1 		$17.1M Buy
92,895
+4,003
+5% +$716K ﹤0.01% 2829
2018
Q4 		$15.9M Buy
88,892
+87
+0.1% +$19K ﹤0.01% 2848
2018
Q3 		$28.4M Buy
88,805
+1,425
+2% +$506K ﹤0.01% 2688
2018
Q2 		$35M Buy
87,380
+12,441
+17% +$5.44M ﹤0.01% 2556
2018
Q1 		$26.9M Buy
74,939
+204
+0.3% +$75.8K ﹤0.01% 2604
2017
Q4 		$29.6M Buy
74,735
+9,809
+15% +$4.06M ﹤0.01% 2577
2017
Q3 		$27.7M Buy
64,926
+15,557
+32% +$4.18M ﹤0.01% 2619
2017
Q2 		$7.9M Buy
49,369
+39,069
+379% +$5.33M ﹤0.01% 3296
2017
Q1 		$1.29M Buy
+10,300
New +$1.33M ﹤0.01% 3760
2016
Q2 		– Sell
-14
Closed -$1K – 3709
2016
Q1 		$1K Buy
+14
New +$927 ﹤0.01% 3501

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock's ABEO Position: Q1 2026 in Review

BlackRock increased its Abeona Therapeutics (ABEO) stake by 1.1% in Q1 2026, buying an estimated $178K and bringing the position to 3,195,530 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3272.

BlackRock first reported a position in ABEO in Q1 2016 and has held it in 38 quarters since. The position peaked at $35M in Q2 2018. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • BlackRock held 3,195,530 shares of Abeona Therapeutics worth $14.3M as of Q1 2026.
  • BlackRock bought 35,667 Abeona Therapeutics shares in Q1 2026, an estimated $178K.
  • Abeona Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3272 holding.
  • BlackRock first reported a position in Abeona Therapeutics in Q1 2016 and has held it in 38 quarters since.
  • BlackRock's Abeona Therapeutics position peaked at $35M in Q2 2018.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.